To the Editor:
A decade after the publication of the STROBE (STrengthening the Reporting of Observational studies in Epidemiology) Statement, we use this anniversary as a time to reflect on STROBE’s impact and future avenues for addressing the incomplete reporting of observational studies.1,2 As an aid to authors, the STROBE Statement and an explanation and elaboration article were published in 2007 with generic guidance for reporting cohort, case–control, or cross-sectional studies. Subsequently, several extensions to STROBE were published, some including authors involved in the original Statement, to provide more nuanced and tailored guidance.3–15 In principal, these efforts are valuable, but inconsistencies may arise because extension production is not coordinated, and there is no clear guidance on their creation.
We qualitatively assessed the published STROBE extensions to identity perceived gaps and deficiencies in the current STROBE checklist and to detect nonspecific or redundant guidance. As detailed in the protocol,16 as of 1 March2017, we found 13 STROBE extensions.3–15 Collectively, there were 298 additions to the STROBE checklist (Table 1). Most additions were directly related to the field on which the extension was focused but, based on independent coding by two reviewers, over one third were not specific to the extension’s field. Rather, they were general epidemiologic or methodologic tenets applicable to most observational research (e.g., details about potential confounders, biases, etc.). The Methods section contained the most changed or added items, one third of which were nonspecific changes (Table 1).
TABLE 1.
Qualitative Assessment of Extensions to STROBE Checklist

Nonspecific additions were mainly in the following areas (Table 2):
TABLE 2.
Examples of Nonspecific Additions Added in STROBE Extensions

Participants, including sample size rationale, changes in exposure status, time points of assessment, and recruitment details;
Potential confounders and biases;
Subgroup and sensitivity analyses;
Generalizability;
Ethics disclosure/approval; and
Access to supplemental information (e.g., open source data, code, or protocols).
These results, highlighting nonspecific recommendations, complement previous research demonstrating particular problems with the reporting of bias, study size calculations, and subgroup and sensitivity analyses.17,18 Nonspecific additions were of particular concern when they were found to be nearly identical to original STROBE checklist items (Table 3).
TABLE 3.
Examples of Redundant Suggestions

While the focused nature of the extensions varies widely, nonspecific additions could represent perceived gaps in content or indicate that information in the explanation and elaboration should be included in the checklist. Checklists provide valuable structure to research articles and serve as a reminder of what should be considered while writing. One cannot expect that all relevant epidemiologic or statistical information will be included; however, the trend of extensions adding general epidemiologic tenets points to a different reality.
The majority of additions made across the extensions were valuable, field-specific recommendations that experts in their respective disciplines determined necessary to report. However, nonspecific and redundant suggestions should not be ignored. EQUATOR (the Enhancing the QUAlity and Transparency Of health Research) Network guidance for guideline developers is a useful starting point to the process of how to develop an extension,19 but more direction is needed in terms of what to report about the process. For example, why it was deemed necessary to duplicate existing items in different words or to add nonspecific information.
Erik von Elm conceived of reporting guidelines as life jackets, not strait jackets.20 STROBE is not meant to be a strict and rigid list, hence why many authors have used it as a base for their own more focused extensions. However, redundant or nonspecific content additions may create confusion rather than help. STROBE is an “evolving document that requires continual assessment, refinement, and if necessary change.”2 The adaptable nature of STROBE is indispensable to its successful implementation. Updating STROBE was discussed at a 2010 meeting,21 but only minor revisions were identified, thus not justifying a new version of the guidelines; perhaps, this should now be reconsidered.
Melissa K. Sharp
Department of Psychology
Faculty of Humanities and Social Sciences
University of Split
Split, Croatia
INSERM
U1153 Epidemiology and Biostatistics
Sorbonne Paris Cité Research Center (CRESS)
Methods of therapeutic evaluation of chronic diseases Team (METHODS)
Paris France
Paris Descartes University
Sorbonne Paris Cité
France
msharp@unist.hr; melissa.sharp@etu.parisdescartes.fr
Darko Hren
Department of Psychology
Faculty of Humanities and Social Sciences
University of Split
Split, Croatia
Douglas G. Altman†
Centre for Statistics in Medicine
University of Oxford, Oxford
United Kingdom
Footnotes
Funding for this project has been provided by the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No 676207. The EQUATOR Network has been and is supported by the UK NHS National Institute for Health Research, UK Medical Research Council, Cancer Research UK and the Pan American Health
D.G.A. is a co-founder of the EQUATOR Network and the Director of the UK EQUATOR Centre. He has been involved in the creation of several reporting guidelines, such as Consolidated Standards of Reporting Trials (CONSORT), Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), STrengthening the Reporting of OBservational studies in Epidemiology (STROBE), and REporting recommendations for tumour MARKer prognostic studies (REMARK). The EQUATOR Network is also a member of the Methods in Research on Research Network, which D.G.A., D.H., and M.K.S. are members of. M.K.S. has a placement with the EQUATOR Network as part of her doctoral studies.
Deceased 3 June 2018.
REFERENCES
- 1.von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology. 2007;18:800–804.. [DOI] [PubMed] [Google Scholar]
- 2.Vandenbroucke JP, von Elm E, Altman DG, et al. ; STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology. 2007;18:805–835.. [DOI] [PubMed] [Google Scholar]
- 3.Gallo V, Egger M, McCormack V, et al. STrengthening the Reporting of OBservational studies in Epidemiology—Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement. Eur J Clin Invest. 2012;42:1–16.. [DOI] [PubMed] [Google Scholar]
- 4.Field N, Cohen T, Struelens MJ, et al. Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statement. Lancet Infect Dis. 2014;14:341–352.. [DOI] [PubMed] [Google Scholar]
- 5.Dixon WG, Carmona L, Finckh A, et al. EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology. Ann Rheum Dis. 2010;69:1596. [DOI] [PubMed] [Google Scholar]
- 6.Benchimol EI, Manuel DG, To T, Griffiths AM, Rabeneck L, Guttmann A. Development and use of reporting guidelines for assessing the quality of validation studies of health administrative data. J Clin Epidemiol. 2011;64:821–829.. [DOI] [PubMed] [Google Scholar]
- 7.Little J, Higgins JP, Ioannidis JP, et al. ; STrengthening the REporting of Genetic Association Studies. STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med. 2009;6:e22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Lachat C, Hawwash D, Ocké MC, et al. Strengthening the Reporting of Observational Studies in Epidemiology-Nutritional Epidemiology (STROBE-nut): an extension of the STROBE statement. PLoS Med. 2016;13:e1002036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Horby PW, Laurie KL, Cowling BJ, et al. ; CONSISE Steering Committee. CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement. Influenza Other Respir Viruses. 2017;11:2–14.. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Cheng A, Kessler D, Mackinnon R, et al. ; International Network for Simulation-based Pediatric Innovation, Research, and Education (INSPIRE) Reporting Guidelines Investigators. Reporting guidelines for health care simulation research: extensions to the CONSORT and STROBE statements. Adv Simul (Lond). 2016;1:25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Fitchett EJA, Seale AC, Vergnano S, et al. ; SPRING (Strengthening Publications Reporting Infection in Newborns Globally) Group. Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research. Lancet Infect Dis. 2016;16:e202–e213.. [DOI] [PubMed] [Google Scholar]
- 12.Tacconelli E, Cataldo MA, Paul M, et al. STROBE-AMS: recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship. BMJ Open. 2016;6:e010134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Creinin MD, Chen MJ. Medical abortion reporting of efficacy: the MARE guidelines. Contraception. 2016;94:97–103.. [DOI] [PubMed] [Google Scholar]
- 14.White RG, Hakim AJ, Salganik MJ, et al. Strengthening the Reporting of Observational Studies in Epidemiology for respondent-driven sampling studies: “STROBE-RDS” statement. J Clin Epidemiol. 2015;68:1463–1471.. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.O’Connor AM, Sargeant JM, Dohoo IR, et al. Explanation and elaboration document for the STROBE-Vet statement: strengthening the reporting of observational studies in epidemiology—veterinary extension. Zoonoses Public Health. 2016;63:662–698.. [DOI] [PubMed] [Google Scholar]
- 16.Sharp MK, Utrobičić A, Gómez G, Cobo E, Wager E, Hren D. The STROBE extensions: protocol for a qualitative assessment of content and a survey of endorsement. BMJ Open. 2017;7:e019043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Langan S, Schmitt J, Coenraads PJ, Svensson A, von Elm E, Williams H; European Dermato-Epidemiology Network (EDEN). The reporting of observational research studies in dermatology journals: a literature-based study. Arch Dermatol. 2010;146:534–541.. [DOI] [PubMed] [Google Scholar]
- 18.Agha RA, Lee SY, Jeong KJ, Fowler AJ, Orgill DP. Reporting quality of observational studies in plastic surgery needs improvement: a systematic review. Ann Plast Surg. 2016;76:585–589.. [DOI] [PubMed] [Google Scholar]
- 19.Moher D, Schulz KF, Simera I, Altman DG. Guidance for developers of health research reporting guidelines. PLoS Med. 2010;7:e1000217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.The Epidemiology Monitor. Exclusive interview with developers of STROBE guidelines for reporting of epidemiologic studies. Epi Monitor (November 2007) [Google Scholar]
- 21.Cevallos M, Egger M. Moher D, Altman DG, Schulz K, Simera I, Wager E; Chapter 17, STrengthening the Reporting of Observational studies in Epidemiology. In: Guidelines for Reporting Health Research: A User’s Manual, First Edition. 20141st ed Hoboken, New Jersey; John Wiley & Sons, Ltd: [Google Scholar]
